KAI1 a new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma

Hepatology

Volumn 28, Issue 6, 1998, Pages 1481-1488

  Guo, Xiao Zhong ^a   Friess, Helmut ^a   Di Mola, Fabio Francesco ^a   Heinicke, Jean Marc ^a   Abou Shady, Mohamed ^a   Graber, Hans U ^a   Baer, Hans U ^a   Zimmermann, Arthur ^a   Korc, Murray ^b   Büchler, Markus W ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; CORRELATION FUNCTION; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER CELL CARCINOMA; LYMPH NODE METASTASIS; MALE; MULTIGENE FAMILY; NORTHERN BLOTTING; PERITONEUM METASTASIS; PRIORITY JOURNAL; SUPPRESSOR GENE; TISSUE DISTRIBUTION;

EID: 0031737790     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510280606     Document Type: Article

References (25)

1. Ikeda k, Saitou S, Tsubota A, Arase Y, Chayama K, Kumada H, Watanabe G, et al. Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer 1993;71:19-25.
2. Arii S, TanakaJ, Yamazoe Y, Minematsu S, Morino T, Fujita K, Maetanl S, et al. Predictive factors for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomy. Cancer 1992;69:913-919.
3. Zamanaka N, Okamoto E, Toyosaka A, Mitunobu M, Fujihara S, Kato T, Fujimoto J, et al. Prognostic factors after hepatectomy for hepatocellular carcinomas. Cancer 1990;65:1104-1110.
4. Shirabe K, Kanematsu T, Matsumata T, Adachi E, Akazawa K, Sugimachi K. Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses. HEPATOLOGY 1991;14:802-805.
5. Nicolson GL. Tumor cell instability, diversification, and progression to the metastatic phenotype: From oncogene to oncofetal expression. Cancer Res 1987;47:1473-1487.
6. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 1991;64:327-336.
7. Aznavoorian S, Murphy A, Stetler-Stevenson W, Liotta L. Molecular aspects of tumor cell invasion and metastasis. Cancer 1993;71:1368-1383.
8. Nakayama T, Ohtsuru A, Nakao K, Shima M, Nakata K, Watanabe K, Ishii N, et al. Expression in human hepatocellular carcinoma of nucleoside diphosphate kinase, a homologue of the nm23 gene product. J Natl Cancer Inst 1992;84:1349-1354.
9. lizuka N, Oka M, Noma T, Nakazawa A, Hirose K, Suzuki T. Nm-23-H1 and nm23-H2 messenger RNA abundance in human hepatocellular carcinoma. Cancer Res 1995;55:652-657.
10. Dong JT, Lamb PW, Rinker-Schaeffer CVV, Vukanovic J, Ichikawa T, Isaacs JT, Barrett JC. KAI-1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 1995;268:884-886.
11. Guo XY, Friess H, Graber HU, Kashiwagi M, Zimmermann A, Korc M, Büchler MW. KA11 expression is upregulated in early pancreatic cancer and decreased in the presence of metastases. Cancer Res 1996;56:4876-4880.
12. Metzelaar MJ, Wijngaard PLJ, Peters PJ, Sixma JJ, Nieuwenhuis HK, Clevers HC. CD63 antigen. J Biol Chem 1991;266:3239-3245.
13. Miyake M, Koyama M, Seno M, Ikeyama S. Identification of the motility related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility. Exp J Med 1991;174:1347-1354.
14. Oren R, Takahashi S, Doss C, Levy R, Levy S. TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins. Mol Cell Biol 1990;10:4007-4015.
15. Szala S, Kasai Y, Steplewski Z, Rodeck U, Koprowski H, Linnenbach AJ. Molecular cloning of cDNA for the human tumor-associated antigen CO-029 and identification of related transmembrane antigens. Proc Natl Acad Sci U S A 1990;87:6833-6837.
16. Wright MD, Henkle KJ, Mitchell GE An immunogenic M 23,000 integral membrane protein of schistosoma mansoni worms that closely resembles a human tumor-associated antigen. J Immunol 1990;144:3195-3200.
17. Classon BJ, Williams AF, Willis AC, Seed B, Stamenkovic I. The primary structure of the human leukocyte antigen CD37, a species homologue of the rat MRC OX-44 antigen. J Exp Med 1989;169:1497-1502.
18. Horejsi V, Vlcek C. Novel structurally distinct family of leucocyte surface glycoproteins including CD9, CD37, CD53 and CD63. FEBS Lett 1991;288:1-4.
19. Schalken JA, Ebeling SB, Isaacs JT, Treiger B, Bussemakers MJG, de Jong MEM, Van de Ven WJM. Down modulation of fibronectin messenger RNA in metastasizing rat prostatic cancer cells revealed by differential hybridization analysis. Cancer Res 1988;48:2042-2046.
20. Adachi M, Taki T, Ieki Y, Huang CI, Higashiyama M, Miyake M. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res 1996;56:1751-1755.
21. Hermanek P, Sobin LH. (eds). TNM classification of malignant tumors, 4th. ed. Union International Contre Cancer: Geneva, pp. 71-73. New York: Springer-Verlag, 1992.
22. Edmondson HA, Steiner PE. Primary carcinoma of the liver. A study of 100 cases among 48900 necropsies. Cancer 1954;7:462-503.
23. Müller CF, Fatzer R, Beek K, Vandevelde M, Zurbriggen A. Studies on canine distemper virus persistence in the control nervous system. Acta Neuropathol 1995;89:438-455.
24. Cox KH, DeLeon DV, Angerer LM, Angerer RC. Detection of mRNAs in sea urchin embryos by in situ hybridization using asymmetric RNA probes. Dev Bio 1984;101:485-502.
25. Korc M, Chandrasekar B, Yamanaka Y, Friess H, Büchler M, Beger HG. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increase in levels of epidermal growth factor and transforming growth factor alpha. J Clin Invest 1992;90:1353-1360.